Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-10

Clinical Trial Update: Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 study completed evaluating whether Vitamin D3 supplementation modulates 15-prostaglandin dehydrogenase expression in Barrett's Esophagus (short and lo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D3 (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Short Segment Barrett's Esophagus, Long Segment Barrett's Esophagus | EARLY_Phase 1 | Status: COMPLETED